XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Return On Equity

Annual ROE:

185.16%+509.36%(+157.11%)
December 31, 2024

Summary

  • As of today, XERS annual return on equity is 185.16%, with the most recent change of +509.36% (+157.11%) on December 31, 2024.
  • During the last 3 years, XERS annual ROE has risen by +375.44% (+197.31%).
  • XERS annual ROE is now at all-time high.

Performance

XERS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSprofitability metrics

Quarterly ROE:

113.91%-46.57%(-29.02%)
June 30, 2025

Summary

  • As of today, XERS quarterly return on equity is 113.91%, with the most recent change of -46.57% (-29.02%) on June 30, 2025.
  • Over the past year, XERS quarterly ROE has dropped by -645.33% (-85.00%).
  • XERS quarterly ROE is now -85.00% below its all-time high of 759.24%, reached on June 30, 2024.

Performance

XERS Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

XERS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+157.1%-85.0%
3Y3 Years+197.3%+147.2%
5Y5 Years+166.2%+135.2%

XERS ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+157.1%-85.0%+111.2%
5Y5-Yearat high+149.0%-85.0%+111.2%
All-TimeAll-Timeat high+149.0%-85.0%+111.2%

XERS ROE History

DateAnnualQuarterly
Jun 2025
-
113.91%(-29.0%)
Mar 2025
-
160.48%(-36.8%)
Dec 2024
185.16%(+157.1%)
253.86%(-36.1%)
Sep 2024
-
397.13%(-47.7%)
Jun 2024
-
759.24%(+174.5%)
Mar 2024
-
-1019.20%(-181.5%)
Dec 2023
-324.20%(-140.5%)
-362.12%(-73.2%)
Sep 2023
-
-209.08%(-27.5%)
Jun 2023
-
-163.95%(-26.8%)
Mar 2023
-
-129.34%(+0.0%)
Dec 2022
-134.83%(+29.1%)
-129.37%(+37.9%)
Sep 2022
-
-208.23%(+13.8%)
Jun 2022
-
-241.47%(+11.3%)
Mar 2022
-
-272.24%(+15.3%)
Dec 2021
-190.28%
-321.60%(+24.6%)
Sep 2021
-
-426.67%(-39.3%)
DateAnnualQuarterly
Jun 2021
-
-306.33%(-9.7%)
Mar 2021
-
-279.18%(+30.2%)
Dec 2020
-378.20%(-35.3%)
-399.80%(+3.2%)
Sep 2020
-
-413.17%(-27.8%)
Jun 2020
-
-323.33%(-33.4%)
Mar 2020
-
-242.44%(-21.8%)
Dec 2019
-279.56%(-168.6%)
-199.09%(-39.7%)
Sep 2019
-
-142.55%(-38.8%)
Jun 2019
-
-102.70%(-17.4%)
Mar 2019
-
-87.48%(-13.8%)
Dec 2018
-104.08%(-39.2%)
-76.85%(-28.8%)
Sep 2018
-
-59.65%(+59.6%)
Jun 2018
-
-147.83%(-195.0%)
Mar 2018
-
155.60%(+639.2%)
Dec 2017
-74.79%(-75.3%)
21.05%
Dec 2016
-42.66%
-

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual return on equity?
  • What is the all-time high annual ROE for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual ROE year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly ROE year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual return on equity?

The current annual ROE of XERS is 185.16%

What is the all-time high annual ROE for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual return on equity is 185.16%

What is Xeris Biopharma Holdings, Inc. annual ROE year-on-year change?

Over the past year, XERS annual return on equity has changed by +509.36% (+157.11%)

What is Xeris Biopharma Holdings, Inc. quarterly return on equity?

The current quarterly ROE of XERS is 113.91%

What is the all-time high quarterly ROE for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly return on equity is 759.24%

What is Xeris Biopharma Holdings, Inc. quarterly ROE year-on-year change?

Over the past year, XERS quarterly return on equity has changed by -645.33% (-85.00%)
On this page